Trial NCT02530437

View at ClinicalTrials.gov 
Org. Study IDs: 2014-0966
Secondary IDs: 2014-0966 NCI-2015-01554

Last trial update was posted on 2023-07-10

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Paclitaxel

MeSH Conditions

Adenocarcinoma Esophageal Neoplasms

Other Conditions

Gastroesophageal Junction Adenocarcinoma Stage IB Esophageal Adenocarcinoma AJCC v7 Stage II Esophageal Adenocarcinoma AJCC v7 Stage IIA Esophageal Adenocarcinoma AJCC v7 Stage IIB Esophageal Adenocarcinoma AJCC v7 Stage IIIA Esophageal Adenocarcinoma AJCC v7 Stage IIIB Esophageal Adenocarcinoma AJCC v7

Stopping Reasons

The sponsor sold the drug TALADEGIB to another company during the trial and thereafter no drug was available. The sponsor made a decision to stop development of this drug Taladegib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID